MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-17-0004750
Viakos Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹30.87 Lakh
▲ 71% YoY
Net profit · FY 2024
₹14,522
Net margin 0.5%
EBITDA · FY 2024
₹19,614
EBITDA margin 0.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
3
Provident fund records
Directors on board
2
As per MCA filings
About Viakos Pharmaceuticals Private Limited
Data last updated:
Viakos Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2020PTC345429. Its GSTIN is 27AAHCV5834D1Z8 (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hemant Ghanshyam Gupta (Member) and Prabhjot Sahani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop E – 25 Devshrushthi Complex Bldg – 1 Vasai Palghar Vasai – Virar City (M Corp), Mumbai, Maharashtra, India – 401203.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.87 Lakh, a growth of 71% compared to the previous year. For the same year it recorded a net profit of ₹14,522 (net margin 0.5%) and EBITDA of ₹19,614 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
The company has about 3 employees on its provident fund (EPFO) records.
Viakos Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0004750). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website viakospharma.com.
Company details
CIN U24304MH2020PTC345429
Registration Number 345429
Incorporation Date 05 September 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0004750
CIN history
Viakos Pharmaceuticals has one previous CIN (Corporate Identification Number): U24304MH2020OPC345429. The current CIN is U24304MH2020PTC345429, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24304MH2020PTC345429 | Current |
| U24304MH2020OPC345429 | Previous |
Recognitions & Rankings of Viakos Pharmaceuticals
Contact details
Viakos Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is viakospharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop E – 25 Devshrushthi Complex Bldg – 1 Vasai Palghar Vasai – Virar City (M Corp), Mumbai, Maharashtra, India – 401203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Viakos Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Viakos Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Viakos Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Viakos Pharmaceuticals Private Limited, buy the company report.
Financials of Viakos Pharmaceuticals Private Limited
FY 2024 filings availableViakos Pharmaceuticals Private Limited reported revenue of ₹30.87 Lakh (up 71% YoY) for FY 2024.
Revenue · FY 2024
₹30.87 Lakh ▲ 71%
Net profit · FY 2024
₹14,522 margin 0.5%
EBITDA · FY 2024
₹19,614 margin 0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 44%
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 71% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹19,614 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹14,522 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.6% | |||
| Net Profit Margin | 0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Viakos Pharmaceuticals Private Limited, buy the company report.
Board of directors of Viakos Pharmaceuticals Private Limited
Viakos Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhjot Sahani | Additional Director | 16 Jun 2023 | 3 Years 4 Months | Current |
| Hemant Ghanshyam Gupta | Member | 26 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Viakos Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amiranz Pharmaceuticals Private Limited | ₹31.05 Lakh (FY 2024) | 26.0% | Kushinagar, Uttar Pradesh, India | |||
| Rainvis Pharmaceuticals Private Limited | ₹31.04 Lakh (FY 2019) | -4.0% | Ahmedabad, Gujarat, India | |||
| Viakos Pharmaceuticals Private Limitedthis company | ₹30.87 Lakh (FY 2024) | ₹14,522 | 0.5% | 71.0% | Mumbai, Maharashtra, India | |
| Bilstein Life Sciences Private Limited | ₹30.83 Lakh (FY 2023) | 74.0% | Chennai, Tamil Nadu, India | |||
| Klyvus Private Limited | ₹30.8 Lakh (FY 2025) | 5.0% | Bangalore, Karnataka, India | |||
| Macklin Pharmaceuticals Private Limited | ₹30.74 Lakh (FY 2025) | 37.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Viakos Pharmaceuticals Private Limited, buy the company report.
Auditor
Viakos Pharmaceuticals Private Limited is audited by RAKESH MISHRA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAKESH MISHRA & ASSOCIATES | FY 2023 | 144715 |
Shareholding
The shareholding of Viakos Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Viakos Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Viakos Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Viakos Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Viakos Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCV5834D1Z8 | Maharashtra | Active | 22 Sep 2020 |
To see the full GST registrations and return filing status of Viakos Pharmaceuticals Private Limited, buy the company report.
Recent activity
Viakos Pharmaceuticals Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Prabhjot Sahani was appointed as Additional Director on 16 Jun 2023.
AGM
Viakos Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Viakos Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Prabhjot Sahani was appointed as Additional Director.
Ceased
Alisha Akhtar Hussain ceased to be Director.
Appointed
Hemant Ghanshyam Gupta was appointed as Member.
Ceased
Deepika Vikas Chavan ceased to be Nominee.
Incorporation
05 Sep 2020
Viakos Pharmaceuticals Private Limited was registered on 05 Sep 2020 with Roc Mumbai & aged 6 years 2 months as per MCA records.
Frequently asked questions
Viakos Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 September 2020 (6+ years old) and is registered under CIN U24304MH2020PTC345429.
Viakos Pharmaceuticals has 2 current directors:
- Prabhjot Sahani - Additional Director
- Hemant Ghanshyam Gupta - Member
The latest financial statements of Viakos Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Viakos Pharmaceuticals is 27AAHCV5834D1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Viakos Pharmaceuticals is U24304MH2020PTC345429. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Viakos Pharmaceuticals was incorporated on 05 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Viakos Pharmaceuticals by revenue are Amiranz Pharmaceuticals Private Limited, Rainvis Pharmaceuticals Private Limited, Bilstein Life Sciences Private Limited, Klyvus Private Limited, Macklin Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Prabhjot Sahani was appointed as Additional Director on 16 Jun 2023. Alisha Akhtar Hussain ceased to be Director on 01 Jul 2022. Hemant Ghanshyam Gupta was appointed as Member on 26 May 2022. Viakos Pharmaceuticals has 4 board changes on record in total.
Yes, Viakos Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0004750).
Viakos Pharmaceuticals can be reached through the website viakospharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Viakos Pharmaceuticals is at Shop E – 25 Devshrushthi Complex Bldg – 1 Vasai Palghar Vasai – Virar City M Corp, Mumbai, Maharashtra, India – 401203.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages